PHYSICAL THERAPY HOME REHABILITATION PROGRAMS WITH AND WITHOUT ACTION OBSERVATION EXECUTION FOR SUBACUTE STROKE PATIENTS

Phase 1

• Conditions: Health conditions:Patients with first ever unilateral right MCA ischemic stroke both cortical and sub cortical at sub acute stage (1 to 6 months), having confirmatory diagnosis from CT scan or MRI; WMFT; sub acute stroke; upper extremity motor function; functional activities; HRQoL; physical therapy home rehabilitation program; AOE; Economic evaluation

• Registration Number: TCTR20200207001
• Lead Sponsor: Asst.Prof.Dr. Pakaratee Chaiyawat

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-02-07
• Study Completion: 2020-05-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

(1) Age between 45 †80 years.
(2) Impaired upper extremity motor function indicating ‘mild to moderate’ level (motor and coordination scores 31 to 55 out of max 66 on Fugl-Meyer assessment (FMA) for upper extremity (UE) (88).
(3) Right handed prior to stroke (Edinburgh handedness inventory score right handed ≥ 7 out of 10) (108).
(4) Normal or corrected vision (NIHSS-visual field = 0 out of 0-3) (109).
(5) Willingness to participate and able to provide informed consent.
(6) Family/care giver available.
(7) Living in or around (20 km radius area) Surakarta, Central Java, Indonesia.

Exclusion Criteria

(1) Severe pain on upper extremity that interferes activities of daily living as indicated by FMA-UE pain = 0 (marked pain) on ≥ 3 out of 5 joints (88).
(2) Evidence of visual neglect or anosognosia (NIHSS neglect item ≥ 1 out of 0-2) (109).
(3) Severely restricted passive range of motion at shoulder and elbow (FMA-UE passive joint motion = 0 out of 0-2 on shoulder and elbow) (88).
(4) Severe to total sensory loss in UE (NIHSS-sensory = 2 out of 0-2) (109).
(5) Cognitive impairments (MMSE < 24 out of 0-30) (107).
(6) Unstable participants due to severe concomitant disease, such as psychiatric (depression, anxiety) pulmonary, cardiovascular or other systemic diseases (severe hypertension, diabetes), verification from the medical record.
(7) Aphasia, verification from the medical record.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Wolf motor function test pre, post and follow up time (second) and functional (rating scale)

Secondary Outcome Measures

Name	Time	Method
Barthel Index pre, post and follow up Rating scale,Euro Qol 5D - 3L pre, post and follow up Rating scale